Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'

NCT: NCT06336044 · RECRUITING

NCT IDNCT06336044
StatusRECRUITING
Start Date2026-11
Completion2027-04
SponsorTaumedika s.r.l. (INDUSTRY)
First posted
Last updated

Brief Summary

Study to validate the safety and efficacy of the Hyaluronic Acid +Collagen filler 40 patients will undergo through 3 visits one to asses the health and apply the filler one after 4 weeks to check the results one after 16 weeks for the final check and results validation Safety assessed with analysis of the Adverse Events

Frequently Asked Questions

What is Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'?

Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen' is a clinical trial registered under NCT06336044. Current status: RECRUITING.

What is the status of NCT06336044?

The current status of NCT06336044 (Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen') is: RECRUITING.

When did Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen' start?

Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen' started on 2026-11.

Related Devices

PMA P000054Filler, recombinant human bone morphogenetic protein, collagen scaffold, osteoinductionMedtronic Sofamor Danek USA, Inc. PMA P000058Filler, recombinant human bone morphogenetic protein, collagen scaffold with metal prosthesis, osteoinductionMedtronic Sofamor Danek USA, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑